AstraZeneca has high hopes for the in-development AZD9291, a treatment for lung cancer expected to bring in $3 billion a year at its peak, and the drugmaker is working with rival Roche to craft a blood test that can spot ideal patients for the therapy.

…read more

Source: AstraZeneca reaches out to Roche with a would-be cancer blockbuster


0 No comments